Trials / Completed
CompletedNCT00997594
Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Mie University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate changes in adrenal hormones during adrenal radiofrequency (RF) ablation.
Detailed description
Adrenal radiofrequency (RF) ablation has been increasingly used for the treatment of unresectable adrenal tumors. But one of the major complication is a increase in blood pressure. Hormonal release during RF ablation is considered the cause of hypertension. But there has been no evidence that adrenal hormones affects changes in blood pressure. In this prospective study, we evaluate the changes in adrenal hormones during RF ablation and clarify the cause of hypertensive crisis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Radiofrequency ablation | Radiofrequency (RF) ablation was done after RF electrodes were placed in the adrenal tumor in the adrenal RF ablation group. RF ablation was done after RF electrodes were placed in the targeted abdominal tumors other than adrenal gland in the abdominal RF ablation other than adrenal gland group. |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-10-01
- Completion
- 2010-10-01
- First posted
- 2009-10-19
- Last updated
- 2015-04-28
- Results posted
- 2011-02-23
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00997594. Inclusion in this directory is not an endorsement.